Brief: Aquestive Therapeutics Inc Says Received Notice From Nasdaq Informing Co That It Has Regained Compliance With Nasdaq
13/04/2023 23:04
April 13 (Reuters) - Aquestive Therapeutics Inc
AQST.O :
* AQUESTIVE THERAPEUTICS INC - RECEIVED NOTICE FROM NASDAQ
INFORMING CO THAT IT HAS REGAINED COMPLIANCE WITH NASDAQ
Source text for Eikon: ID:
Further company coverage: AQST.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Announces FDA Acceptance Of Anaphylm™ NDA Resubmission And PDUFA Goal Date Of March 16, 2027
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Aquestive rises on US licensing deal for seizure drug with Eton Pharma